D. M. Citron

768 total citations
22 papers, 592 citations indexed

About

D. M. Citron is a scholar working on Infectious Diseases, Clinical Biochemistry and Endocrinology. According to data from OpenAlex, D. M. Citron has authored 22 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Clinical Biochemistry and 6 papers in Endocrinology. Recurrent topics in D. M. Citron's work include Bacterial Identification and Susceptibility Testing (10 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Streptococcal Infections and Treatments (5 papers). D. M. Citron is often cited by papers focused on Bacterial Identification and Susceptibility Testing (10 papers), Clostridium difficile and Clostridium perfringens research (8 papers) and Streptococcal Infections and Treatments (5 papers). D. M. Citron collaborates with scholars based in United States, Germany and Bulgaria. D. M. Citron's co-authors include Ellie J. C. Goldstein, S M Finegold, E. J. C. Goldstein, Stuart Johnson, Dale N. Gerding, E. J. C. Goldstein, Isabel Figueroa, Susan P. Sambol, F.E. Russell and S M Finegold and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

D. M. Citron

22 papers receiving 543 citations

Peers

D. M. Citron
Marina C. Claros Germany
Lisa L. Dever United States
Bert F. Woolfrey United States
S. Hunt Gerardo United States
Phyllis Della Latta United States
Charlotte Pers Denmark
C A Strong United States
R. Hone Ireland
T. Fosse France
Caroline Loïez France
Marina C. Claros Germany
D. M. Citron
Citations per year, relative to D. M. Citron D. M. Citron (= 1×) peers Marina C. Claros

Countries citing papers authored by D. M. Citron

Since Specialization
Citations

This map shows the geographic impact of D. M. Citron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. M. Citron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. M. Citron more than expected).

Fields of papers citing papers by D. M. Citron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. M. Citron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. M. Citron. The network helps show where D. M. Citron may publish in the future.

Co-authorship network of co-authors of D. M. Citron

This figure shows the co-authorship network connecting the top 25 collaborators of D. M. Citron. A scholar is included among the top collaborators of D. M. Citron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. M. Citron. D. M. Citron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Figueroa, Isabel, Stuart Johnson, Susan P. Sambol, et al.. (2012). Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin. Clinical Infectious Diseases. 55(suppl 2). S104–S109. 105 indexed citations
2.
Citron, D. M., et al.. (2009). Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria. Journal of Antimicrobial Chemotherapy. 63(5). 972–976. 33 indexed citations
3.
Castiglioni, Bianca, Amitabh Gautam, D. M. Citron, et al.. (2003). Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient. Transplant Infectious Disease. 5(4). 199–202. 15 indexed citations
4.
Reilly, Debra, et al.. (2000). Nystatin Powder Does Not Inactivate 5% Mafenide Acetate Solution. Journal of Burn Care & Rehabilitation. 21. S155–S155. 1 indexed citations
5.
Gerardo, S. Hunt, M. Marina, D. M. Citron, et al.. (1997). Bilophila wadsworthiaClinical Isolates Compared by Polymerase Chain Reaction Fingerprinting. Clinical Infectious Diseases. 25(s2). S291–S294. 4 indexed citations
6.
Mulligan, Maury E., D. M. Citron, R Y Kwok, & Ellie J. C. Goldstein. (1997). Immunoblot Characterization ofPorphyromonasSpecies from Infected Dog and Cat Bite Wounds in Humans. Clinical Infectious Diseases. 25(s2). S98–S99. 3 indexed citations
7.
Claros, Marina C., S. Hunt Gerardo, D. M. Citron, et al.. (1997). Use of Polymerase Chain Reaction Fingerprinting to Compare Clinical Isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States. Clinical Infectious Diseases. 25(s2). S295–S298. 6 indexed citations
8.
Hudspeth, Marie K., S. Hunt Gerardo, D. M. Citron, & Ellie J. C. Goldstein. (1997). Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans. Journal of Clinical Microbiology. 35(10). 2450–2453. 13 indexed citations
9.
Goldstein, Ellie J. C., et al.. (1995). Fatal Sepsis Due to a  -Lactamase-Producing Strain of Fusobacterium nucleatum subspecies polymorphum. Clinical Infectious Diseases. 20(4). 797–800. 30 indexed citations
10.
Appelbaum, Peter C., S K Spangler, Glenn A. Pankuch, et al.. (1994). Characterization of a β-lactamase from Clostridium clostridioforme. Journal of Antimicrobial Chemotherapy. 33(1). 33–40. 32 indexed citations
11.
Goldstein, Ellie J. C., D. M. Citron, & Ronald Goldman. (1992). National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement. Journal of Clinical Microbiology. 30(6). 1529–1534. 32 indexed citations
12.
Goldstein, Ellie J. C., D. M. Citron, & Charles E. Cherubin. (1991). Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group. Antimicrobial Agents and Chemotherapy. 35(9). 1868–1874. 11 indexed citations
13.
Goldstein, Ellie J. C., D. M. Citron, & Charles E. Cherubin. (1991). Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations. Antimicrobial Agents and Chemotherapy. 35(3). 560–566. 27 indexed citations
14.
Citron, D. M., E. J. Baron, S M Finegold, & Ellie J. C. Goldstein. (1990). Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species. Journal of Clinical Microbiology. 28(10). 2220–2223. 16 indexed citations
15.
16.
Goldstein, E. J. C., et al.. (1987). Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.. PubMed. 82(4A). 284–7. 20 indexed citations
17.
Citron, D. M., et al.. (1986). Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals. Antimicrobial Agents and Chemotherapy. 29(1). 158–160. 22 indexed citations
18.
Kirby, Barbara D., W. Lance George, Vera L. Sutter, D. M. Citron, & S M Finegold. (1980). Gram-Negative Anaerobic Bacilli: Their Role in Infection and Patterns of Susceptibility to Antimicrobial Agents. I. Little-Known Bacteroides Species. Clinical Infectious Diseases. 2(6). 914–951. 61 indexed citations
19.
Kirby, Barbara D., David F. Busch, D. M. Citron, & S M Finegold. (1979). Cefoxitin for Treatment of Infections Due to Anaerobic Bacteria. Clinical Infectious Diseases. 1(1). 113–116. 14 indexed citations
20.
Goldstein, E. J. C., et al.. (1979). Bacteriology of Rattlesnake Venom and Implications for Therapy. The Journal of Infectious Diseases. 140(5). 818–821. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina C. Claros Breakdown of academic impact, for papers by Lisa L. Dever Breakdown of academic impact, for papers by Bert F. Woolfrey Breakdown of academic impact, for papers by S. Hunt Gerardo Breakdown of academic impact, for papers by Phyllis Della Latta Breakdown of academic impact, for papers by Charlotte Pers Breakdown of academic impact, for papers by C A Strong Breakdown of academic impact, for papers by R. Hone Breakdown of academic impact, for papers by T. Fosse Breakdown of academic impact, for papers by Caroline Loïez
Rankless by CCL
2026